Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
Notice with comment period.
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled HIV Capacity Building Assistance (CBA) Program: Data Management, Monitoring, and Evaluation. This data collection aims to determine the short- and long-term outcomes of the CDC HIV CBA program and support continuous quality improvement.
CDC must receive written comments on or before October 5, 2026.
You may submit comments, identified by Docket No. CDC-2026-1321 by either of the following methods:
- Federal eRulemaking Portal:www.regulations.gov.
Follow the instructions for submitting comments. - Mail:
Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS H21-8, Atlanta, Georgia 30329.
Instructions:
All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to
www.regulations.gov.
Please note:
Submit all comments through the Federal eRulemaking portal (
www.regulations.gov) or by U.S. mail to the address listed above.
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the
Federal Register
concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to be collected;
4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology,
e.g.,
permitting electronic submissions of responses; and
5. Assess information collection costs.
Proposed Project
HIV Capacity Building Assistance (CBA) Program: Data Management,
( printed page 50846)
Monitoring, and Evaluation—New—National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) requests approval of non-research program evaluation project that will be conducted to evaluate the CDC HIV Capacity Building Assistance (CBA) program funded under PS24-0020: Capacity Building Assistance for HIV Prevention Programs to End the HIV Epidemic in the United States.
The CDC National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP) is charged with the mission to promote health and quality of life by preventing HIV infection and reducing HIV-related illness and death in the United States. CDC is a key partner in the
Ending the HIV Epidemic in the U.S.
(EHE) initiative, with the goal to reduce new HIV infections by at least 90% by 2030. Toward this aim, DHP partners with and provides CBA to health departments and community-based organizations (CBOs) to improve both individual competencies and organizational capacity to optimally plan, integrate, implement, and sustain comprehensive HIV prevention programs.
This evaluation aims to assess the short- and long-term outcomes of the HIV CBA program and to provide critical feedback that can be used for continuous program quality improvement. The evaluation questions and performance measures developed for this evaluation are guided by the logic model outcomes documented in PS24-0020. The following evaluation questions serve as the lens through which data collection instruments were developed, data are analyzed, and results are used to improve program activities:
What is the reach of the HIV CBA program?
What is the quality of the HIV CBA services provided?
To what extent do HIV CBA services contribute to improving the knowledge, skills, and competency of the HIV prevention workforce?
To what extent does the HIV CBA program strengthen national partnerships for CDC-funded health departments?
To what extent does the HIV CBA program improve capacity for CDC-funded health departments and community-based organizations?
To what extent do CBA marketing efforts result in greater awareness and utilization of CBA services?
These evaluation questions will be answered using pre-defined performance measures that will be calculated leveraging data collected through a combination of web-based applications and survey instruments that require OMB review and approval prior to use. Web-based applications include the CBA Tracking System (CTS)—a web-based application that allows the HIV prevention workforce to request CBA from the HIV CBA program—and CDC Train—a web-based learning management system. The Post-CBA Survey and the CBA Follow-Up Survey were developed and tailored to meet the evaluation needs of this project. These surveys will be administered through CTS. The Post-CBA Survey will be administered to all CBA participants after CBA has been provided. The CBA Follow-Up Survey will be administered to respondents of the Post-CBA Survey who indicate a role in implementation at set three-month time periods. The following table illustrates the alignment between evaluation questions, logic model outcomes, performance measures, and data sources.
CDC requests OMB approval for an estimated 1,668 annual burden hours. There is no cost to the respondents other than their time.
Estimated Annualized Burden Hours
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
CBA participants/HIV prevention workforce
Post-CBA Survey
2,000
4
10/60
1,334
CBA participants/HIV prevention workforce
CBA Follow-Up Survey
500
4
10/60
334
Total
1,668
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention.
